<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-106645</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Ophthalmic manifestations in Mexican patients with Fabry disease</dc:title>
<dc:description xml:lang="en">Fabry disease (FD) is a rare X-linked genetic lysosomal storage disease caused by a deficiency of the enzyme alpha-galactosidase A, that produces accumulation of globotriaosylceramide. There is a multisystemic involvement, including renal, cardiac, eye, and nervous system manifestations. Aim: To perform a descriptive analysis of the ophthalmological manifestations in Mexican patients with FD. Material and methods: We studied 13 patients with clinical and biochemical diagnostic of FD. Results: Cornea verticillata was found in 57% of men and 33% carriers. Conclusion: Cornea verticillata was the most common ocular manifestation in males and carriers of FD in Mexico(AU)</dc:description>
<dc:creator>Ríos-González, B. E</dc:creator>
<dc:creator>Gutiérrez-Amavizca, B. E</dc:creator>
<dc:creator>Beltrán-Becerra, K. J</dc:creator>
<dc:creator>Silva-Noriega, D. A</dc:creator>
<dc:creator>Figuera, L. E</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La enfermedad de Fabry (EF) es una patología genética rara ligada al cromosoma X, de depósito lisosomal, por la deficiencia de la enzima alfa-galactosidasa A, que produce la acumulación de globotriaosilceramida, ocasionando afectación renal, cardiaca, oftalmológica y del sistema nervioso. Objetivo: Realizar un análisis descriptivo de las manifestaciones oftalmológicas en pacientes mexicanos con EF. Material y métodos: Se incluyeron 13 pacientes con diagnóstico clínico y bioquímico de EF. Resultados: La córnea verticilata se encontró en el 57% de varones y en el 33% de portadoras. Conclusión: La córnea verticilata es la manifestación oftalmológica más frecuente en varones afectados y portadoras de EF en México(AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;87(11): 373-375, nov. 2012. tab</dc:source>
<dc:identifier>ibc-106645</dc:identifier>
<dc:title xml:lang="es">Manifestaciones oftalmológicas en pacientes mexicanos con enfermedad de Fabry</dc:title>
<dc:subject>^d3334^s22032</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30299^s22016</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d5231^s22016</dc:subject>
<dc:subject>^d5231^s22032</dc:subject>
<dc:subject>^d30299^s22012</dc:subject>
<dc:subject>^d5231^s22012</dc:subject>
<dc:subject>^d19035^s22012</dc:subject>
<dc:subject>^d3333^s22044</dc:subject>
<dc:subject>^d3333^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>201211</dc:date>
</metadata>
</record>
</ibecs-document>
